HEALTHNY POST
What Ozempic is actually doing to obesity rates in the US
GLP-1 medications like Ozempic are gaining popularity and significantly impacting the health landscape in the US, influencing obesity rates.
Related Signal
Adjacent reporting
- Weight loss drugs GLP-1s are shifting fashion and food trends
- Britain's turning the tide on obesity: Experts say rates have plateaued among children, are slowing in adults and now fat jabs could see the decades-long trend start to reverse
- Experimental obesity drug outperforms traditional weight-loss treatments in early research
- New “Trojan horse” obesity drug supercharges weight loss in early tests
- The ‘velocity of obesity’ aims to show which nations are slowing an epidemic
- Why obesity drugs work better for some people: these genes hold clues